Private Equity and Dental Practices

The useful signal is not a lazy private equity good or private equity bad take. The new evidence suggests private equity changes incentive structure, service mix, and list-price behavior in ways dentists should understand before they sell, buy, or work inside a consolidated platform.

Bottom line

Charges rise faster than negotiated payments

The study summarized by Dental Economics found higher submitted charges after private-equity acquisition, while negotiated or allowed commercial payments remained statistically unchanged. In practical terms, enterprise revenue can improve without clear evidence that payer reimbursement improved.

Procedure mix

Care shifts toward higher-revenue work

Post-acquisition offices tilted away from diagnostic and preventive care and toward restorative, specialty, and surgical work. Implant procedures per visit increased materially over time, which matters if you are trying to separate genuine clinical need from incentive drift.

Patient exposure

List-price growth can still hit self-pay and cost-sharing patients

Even when negotiated insurance payments do not move much, higher submitted charges can still matter because so much dental spending is paid out of pocket. That makes list-price behavior more important in dentistry than in many other areas of health care.

What the study actually found

Private-equity-acquired dental offices raised submitted charges by about 3.3% relative to non-acquired offices.
Allowed or negotiated commercial payments did not move meaningfully after acquisition.
Service mix shifted toward restorative, specialty, and surgical procedures.
Implant procedures per visit rose after acquisition and continued increasing over time.
Root-canal volume per visit did not show the same meaningful change.
Medicaid participation did not materially change after acquisition.
Acquired offices became more likely to operate as multispecialty practices.

What matters for dentists

Selling to PE is not just a valuation decision

It is also a decision about governance, pricing behavior, procedure mix, staffing pressure, and how the office will define success after the deal closes.

Working inside a PE-backed office can change treatment context

If revenue growth is driven more by mix shift and list-price behavior than by payer leverage, the pressure felt by clinicians may show up in case presentation, scheduling, and treatment expectations rather than in better pay.

Payer leverage is not the same as enterprise leverage

The study points toward a distinction many dentists miss: a platform can improve financial performance without clearly winning better negotiated reimbursement from insurers.

What this does not prove

It does not prove every PE-backed office behaves the same way.
It does not prove any individual restorative recommendation is inappropriate.
It does not tell you whether a given clinician or office culture improved or worsened after acquisition.
It does not settle the broader moral argument about DSOs, consolidation, or practice autonomy by itself.
It is still observational research using 2015-2021 transaction, office, and commercial-claims data, so it should be treated as strong directional evidence rather than perfect causal truth.

OnlyDentists read

The strongest takeaway is not that PE magically improves efficiency or that every acquisition harms patients. It is that PE appears to reorient practices toward higher-revenue care while leaving negotiated reimbursement roughly the same. That means dentists should pay close attention to incentive architecture, not just acquisition multiples or back-office talking points.

The Dental Economics article is useful as a readable summary. The underlying Health Services Research paper is where the real evidentiary weight sits. We treat the article as a secondary explainer and the study as the main signal.

Sources

This page is not blanket anti-PE or pro-PE advocacy. It is a practical reading of the evidence for dentists making ownership, employment, and treatment-environment decisions.